Drew Goldstein
Drew Goldstein is the Co-Head of US Healthcare at Palantir. Drew leads Palantir’s efforts to increase capacity, reduce costs, and improve overall hospital performance through Palantir Foundry and AIP. Drew launched Palantir’s initial health system partnerships with Cleveland Clinic, Tampa General Hospital, and HCA Healthcare, and now oversees a broad portfolio that together amounts to more than 17% of the US Healthcare system by admissions. His previous experience includes launching Syntropy, Palantir’s Joint Venture with Merck KGaA, Darmstadt, Germany, to accelerate clinical research activities at MD A